cure it composites limited

Live MatureLargeHealthy

cure it composites limited Company Information

Share CURE IT COMPOSITES LIMITED

Company Number

01797547

Directors

John Gill

Matthew Chialton

View All

Shareholders

giants hall holdings limited

Group Structure

View All

Industry

Specialised construction activities (other than scaffold erection) n.e.c.

 

Registered Address

giants hall willow road, beech hill, wigan, lancashire, WN6 8RY

cure it composites limited Estimated Valuation

£19.7m

Pomanda estimates the enterprise value of CURE IT COMPOSITES LIMITED at £19.7m based on a Turnover of £27.6m and 0.72x industry multiple (adjusted for size and gross margin).

cure it composites limited Estimated Valuation

£27.2m

Pomanda estimates the enterprise value of CURE IT COMPOSITES LIMITED at £27.2m based on an EBITDA of £3.8m and a 7.16x industry multiple (adjusted for size and gross margin).

cure it composites limited Estimated Valuation

£20m

Pomanda estimates the enterprise value of CURE IT COMPOSITES LIMITED at £20m based on Net Assets of £9.4m and 2.13x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Cure It Composites Limited Overview

Cure It Composites Limited is a live company located in wigan, WN6 8RY with a Companies House number of 01797547. It operates in the other specialised construction activities n.e.c. sector, SIC Code 43999. Founded in March 1984, it's largest shareholder is giants hall holdings limited with a 100% stake. Cure It Composites Limited is a mature, large sized company, Pomanda has estimated its turnover at £27.6m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Cure It Composites Limited Health Check

Pomanda's financial health check has awarded Cure It Composites Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 2 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

8 Strong

positive_score

2 Regular

positive_score

2 Weak

size

Size

annual sales of £27.6m, make it larger than the average company (£7.3m)

£27.6m - Cure It Composites Limited

£7.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (11.2%)

5% - Cure It Composites Limited

11.2% - Industry AVG

production

Production

with a gross margin of 32.5%, this company has a lower cost of product (25%)

32.5% - Cure It Composites Limited

25% - Industry AVG

profitability

Profitability

an operating margin of 11.6% make it more profitable than the average company (6.5%)

11.6% - Cure It Composites Limited

6.5% - Industry AVG

employees

Employees

with 101 employees, this is above the industry average (30)

101 - Cure It Composites Limited

30 - Industry AVG

paystructure

Pay Structure

on an average salary of £43.2k, the company has an equivalent pay structure (£48.8k)

£43.2k - Cure It Composites Limited

£48.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £272.8k, this is more efficient (£197.8k)

£272.8k - Cure It Composites Limited

£197.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 42 days, this is earlier than average (54 days)

42 days - Cure It Composites Limited

54 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 35 days, this is close to average (36 days)

35 days - Cure It Composites Limited

36 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 63 days, this is more than average (13 days)

63 days - Cure It Composites Limited

13 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 41 weeks, this is more cash available to meet short term requirements (21 weeks)

41 weeks - Cure It Composites Limited

21 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 31.4%, this is a lower level of debt than the average (60.9%)

31.4% - Cure It Composites Limited

60.9% - Industry AVG

CURE IT COMPOSITES LIMITED financials

EXPORTms excel logo

Cure It Composites Limited's latest turnover from March 2024 is £27.6 million and the company has net assets of £9.4 million. According to their latest financial statements, Cure It Composites Limited has 101 employees and maintains cash reserves of £3 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover27,557,41926,683,76328,643,87924,014,75522,817,51623,983,89920,954,66619,432,84517,325,54215,579,63212,758,0389,185,1667,674,8726,720,0785,947,927
Other Income Or Grants
Cost Of Sales18,602,50420,453,14921,142,97915,804,79316,549,68118,135,06415,599,64213,226,86011,518,04410,754,0348,019,1215,762,3934,799,5703,862,2683,290,057
Gross Profit8,954,9156,230,6147,500,9008,209,9626,267,8355,848,8355,355,0246,205,9855,807,4984,825,5984,738,9173,422,7732,875,3022,857,8102,657,870
Admin Expenses5,755,6934,639,2735,557,3784,016,7474,707,4604,765,6605,182,2564,684,0364,186,7483,642,1793,063,3402,357,6802,185,7582,103,2582,046,025
Operating Profit3,199,2221,591,3411,943,5224,193,2151,560,3751,083,175172,7681,521,9491,620,7501,183,4191,675,5771,065,093689,544754,552611,845
Interest Payable64,042104,2079,0428,98613,73016,71514,98822,97730,71431,94618,14215,51815,38315,77333,002
Interest Receivable51,6219,729284063,4802,6925852,8335,4695,5767,06210,7906,3974,27110,068
Pre-Tax Profit3,186,8011,496,8631,934,5084,184,6351,550,1251,069,152158,3651,501,8051,595,5051,157,0491,664,4971,060,365680,558743,050603,214
Tax-962,401-305,992-416,160-834,824-312,503-218,086-42,149-332,511-344,125-279,801-360,969-225,195-111,068-199,859-174,007
Profit After Tax2,224,4001,190,8711,518,3483,349,8111,237,622851,066116,2161,169,2941,251,380877,2481,303,528835,170569,490543,191429,207
Dividends Paid483,600572,000653,0001,215,148456,613378,235120,00091,50087,70013,70024,00079,00040,00040,00040,000
Retained Profit1,731,926603,031762,0391,894,820766,182448,459-3,7841,077,7941,124,004833,6321,241,233707,087486,683579,363305,787
Employee Costs4,366,4783,761,4383,926,1003,600,8153,752,9293,753,9363,980,6883,612,8633,162,6002,721,3792,232,5691,813,5071,644,5351,395,1051,405,373
Number Of Employees101898994100104968683817758504851
EBITDA*3,796,1602,142,3492,529,1864,824,9842,102,5361,637,352457,0351,986,4461,999,2431,527,6911,925,0901,276,883882,678931,895763,482

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets3,326,8812,654,8502,890,3863,105,5383,166,3593,073,0003,070,4592,860,5373,059,6682,911,7132,291,5131,932,5071,740,1041,654,0991,483,943
Intangible Assets341,8955,76811,53617,30423,07228,84034,608
Investments & Other48,577138,420153,248177,620194,897312,686335,112272,868101,41218,495
Debtors (Due After 1 year)
Total Fixed Assets3,668,7762,654,8502,890,3863,154,1153,304,7793,226,2483,248,0793,055,4343,372,3543,252,5932,575,9172,051,2231,781,6711,682,9391,518,551
Stock & work in progress3,211,9792,934,2294,102,9902,678,7862,821,3823,880,4602,848,2792,403,4542,428,3022,260,0651,891,2831,245,854988,165895,408739,699
Trade Debtors3,230,3763,144,5583,863,7203,837,0062,735,5302,884,1903,395,6743,512,2893,250,2452,596,6522,385,3901,873,9301,362,2991,215,765943,345
Group Debtors412,07269,527290,373
Misc Debtors154,863162,170408,206254,930530,835247,201272,346227,730263,076263,479133,353130,66884,87076,81440,600
Cash3,011,9632,993,625711,5305,180,5623,497,1902,494,3192,080,9492,892,3631,684,0581,111,0061,165,4711,131,4051,148,267951,0771,171,880
misc current assets7,465118,946
total current assets10,021,2539,304,1099,086,44611,951,2849,584,9379,513,6358,716,1949,035,8367,625,6816,521,5755,575,4974,381,8573,583,6013,139,0642,895,524
total assets13,690,02911,958,95911,976,83215,105,39912,889,71612,739,88311,964,27312,091,27010,998,0359,774,1688,151,4146,433,0805,365,2724,822,0034,414,075
Bank overdraft79,05915,39688,470
Bank loan400,000400,00032,53332,53332,53360,875108,183167,061198,528341,834
Trade Creditors 1,802,1121,484,0761,691,606936,7801,184,4742,024,5151,282,1231,271,7721,070,401986,8551,053,721804,467633,076438,734406,740
Group/Directors Accounts25,12527,249282,93323,9203,6744,28413,93932,84767,28783,69827,28543,33843,326
other short term finances290,373
hp & lease commitments86,81045,9146,2922,7199,50055,42359,38166,29484,12664,24075,31532,3481,250
other current liabilities1,903,154852,5691,103,4281,732,8821,140,760735,7111,054,8261,237,3311,194,751802,769711,723493,779309,840392,904359,870
total current liabilities3,817,2012,809,8083,201,3262,955,3142,367,2672,872,1022,432,5372,640,5562,471,4002,344,1452,106,5741,756,1261,049,260890,372899,656
loans1,166,6671,566,667268,399300,933333,466366,000498,533531,066100,000377,824452,324456,324
hp & lease commitments170,408161,15316,2552,71942,86428,52320,46357,56068,66640,435
Accruals and Deferred Income40,000
other liabilities4,0004,000
provisions311,467171,178121,302165,574161,640200,475294,697188,602186,533144,29551,39152,96961,72562,82960,808
total long term liabilities481,8751,498,9981,744,224165,574432,758544,272656,686554,602705,529732,921220,05793,404439,549519,153521,132
total liabilities4,299,0764,308,8064,945,5503,120,8882,800,0253,416,3743,089,2233,195,1583,176,9293,077,0662,326,6311,849,5301,488,8091,409,5251,420,788
net assets9,355,9037,606,2297,003,19811,984,51110,089,6919,323,5098,875,0508,896,1127,821,1066,697,1025,824,7834,583,5503,876,4633,389,7802,810,417
total shareholders funds9,355,9037,606,2297,003,19811,984,51110,089,6919,323,5098,875,0508,896,1127,821,1066,697,1025,824,7834,583,5503,876,4633,389,7802,810,417
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit3,199,2221,591,3411,943,5224,193,2151,560,3751,083,175172,7681,521,9491,620,7501,183,4191,675,5771,065,093689,544754,552611,845
Depreciation583,949551,008585,664631,769542,161554,177284,267464,497372,725338,504203,745206,022187,366171,575119,321
Amortisation12,9895,7685,76845,7685,7685,7685,76832,316
Tax-962,401-305,992-416,160-834,824-312,503-218,086-42,149-332,511-344,125-279,801-360,969-225,195-111,068-199,859-174,007
Stock277,750-1,168,7611,424,204-142,596-1,059,0781,032,181444,825-24,848168,237368,782645,429257,68992,757155,709739,699
Debtors421,056-895,671179,990825,571134,974-536,629-71,999226,698362,817631,761514,145557,429154,590308,634983,945
Creditors318,036-207,530754,826-247,694-840,041742,39210,351201,37183,546-66,866249,254171,391194,34231,994406,740
Accruals and Deferred Income1,050,585-290,859-589,454592,122405,049-319,115-182,50542,580391,98291,046217,944183,939-83,06433,034359,870
Deferred Taxes & Provisions140,28949,876-44,2723,934-38,835-94,222106,0952,06942,23892,904-1,578-8,756-1,1042,02160,808
Cash flow from operations3,643,8633,452,276629,9323,655,5472,240,3101,252,769-23,9991,698,1051,641,830364,431870,167583,144634,437334,742-306,751
Investing Activities
capital expenditure-549,165-761,853-139,668-668,674-929,785-840,556-392,406-273,371-341,731-1,670,188
Change in Investments-48,577-89,843-14,828-24,372-17,277-117,789-22,42662,244171,45682,91718,495
cash flow from investments48,57789,84314,828-524,793-744,576-21,879-646,248-992,029-1,012,012-475,323-291,866-341,731-1,670,188
Financing Activities
Bank loans-400,000400,000-32,533-28,342-47,308-58,878-31,467-143,306341,834
Group/Directors Accounts-2,12427,249-282,933282,933-23,92020,246-610-9,655-18,908-34,440-16,41156,413-16,0531243,326
Other Short Term Loans -290,373290,373
Long term loans-1,166,667-400,0001,566,667-268,399-32,534-32,533-32,534-132,533-32,533431,066100,000-377,824-74,500-4,000456,324
Hire Purchase and Lease Commitments50,151184,52019,828-9,500-86,06810,38321,610-38,295-17,211-22,18171,19872,783-1,2501,250
other long term liabilities-4,0004,000
share issue17,748-5,743,352-17,278-2,78838,6872,504,630
interest-12,421-94,478-9,014-8,580-10,250-14,023-14,403-20,144-25,245-26,370-11,080-4,728-8,986-11,502-22,934
cash flow from financing-1,513,313-282,709-4,048,804-36,079-152,772-15,927-71,557-250,723-443,148645,66840188,478-103,539-16,7402,986,596
cash and cash equivalents
cash18,3382,282,095-4,469,0321,683,3721,002,871413,370-811,4141,208,305573,052-54,46534,066-16,862197,190-220,8031,171,880
overdraft-79,05963,663-73,07488,470
change in cash18,3382,282,095-4,469,0321,683,3721,002,871413,370-811,4141,208,305573,052-54,46534,06662,197133,527-147,7291,083,410

cure it composites limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for cure it composites limited. Get real-time insights into cure it composites limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Cure It Composites Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for cure it composites limited by selecting its closest rivals, whether from the CONSTRUCTION sector, other large companies, companies in WN6 area or any other competitors across 12 key performance metrics.

cure it composites limited Ownership

CURE IT COMPOSITES LIMITED group structure

Cure It Composites Limited has 1 subsidiary company.

Ultimate parent company

1 parent

CURE IT COMPOSITES LIMITED

01797547

1 subsidiary

CURE IT COMPOSITES LIMITED Shareholders

giants hall holdings limited 100%

cure it composites limited directors

Cure It Composites Limited currently has 4 directors. The longest serving directors include Mr John Gill (Sep 1991) and Mr Matthew Chialton (Apr 2012).

officercountryagestartendrole
Mr John Gill74 years Sep 1991- Director
Mr Matthew ChialtonUnited Kingdom45 years Apr 2012- Director
Mr David MoorcroftEngland37 years Aug 2023- Director
Ms Emma HorrobinUnited Kingdom50 years Sep 2024- Director

P&L

March 2024

turnover

27.6m

+3%

operating profit

3.2m

+101%

gross margin

32.5%

+39.17%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

9.4m

+0.23%

total assets

13.7m

+0.14%

cash

3m

+0.01%

net assets

Total assets minus all liabilities

cure it composites limited company details

company number

01797547

Type

Private limited with Share Capital

industry

43999 - Specialised construction activities (other than scaffold erection) n.e.c.

incorporation date

March 1984

age

41

incorporated

UK

ultimate parent company

accounts

Group

last accounts submitted

March 2024

previous names

g. & b. (north west) limited (September 2024)

g and b trailaway limited (September 1987)

accountant

-

auditor

MCDADE ROBERTS ACCOUNTANTS LTD

address

giants hall willow road, beech hill, wigan, lancashire, WN6 8RY

Bank

SVENSKA HANDELSBANKEN AB

Legal Advisor

-

cure it composites limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to cure it composites limited. Currently there are 1 open charges and 4 have been satisfied in the past.

cure it composites limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CURE IT COMPOSITES LIMITED. This can take several minutes, an email will notify you when this has completed.

cure it composites limited Companies House Filings - See Documents

datedescriptionview/download